Abcodia Raises $8M to Support Launch of Ovarian Cancer Screening Test | GenomeWeb

NEW YORK(GenomeWeb) – Diagnostics firm Abcodia said today that it has raised £5.25 million ($8 million) in funding to support launch of its ROCA ovarian cancer test.

The funding was co-led by Cambridge Innovation Capital and Scottish Equity Partners, which joined existing investors Albion Ventures and UCL Business. CIC Investment Director Robert Tansley and SEP Partner Jan Rutherford have been appointed to Abcodia's Board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.